首页> 美国卫生研究院文献>Infection and Drug Resistance >Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients
【2h】

Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients

机译:酶联免疫吸附法诊断艰难梭菌相关性腹泻:谷氨酸脱氢酶阳性患者毒素阴性的临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeThe enzyme immunoassay (EIA) has lower sensitivity for Clostridium difficile toxins A and B than the polymerase chain reaction in the diagnosis of C. difficile-associated diarrhea (CDAD). Furthermore, toxin positivity with EIA performed on C. difficile isolates from stool cultures may be observed even in patients with EIA glutamate dehydrogenase (GDH)-positive and toxin-negative stool specimens. It is unclear whether such patients should be treated as having CDAD.
机译:目的在诊断艰难梭菌相关性腹泻(CDAD)时,酶免疫法(EIA)对艰难梭菌毒素A和B的敏感性低于聚合酶链反应。此外,即使在EIA谷氨酸脱氢酶(GDH)阳性和毒素阴性的粪便标本中,也可以在粪便培养物中的艰难梭菌分离物中进行EIA毒素阳性。尚不清楚是否应将这类患者视为患有CDAD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号